Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment

• मुख्य लेखकों: Vineela Parvathaneni (लेखक), Nishant S. Kulkarni (लेखक), Snehal K. Shukla (लेखक), Pamela T. Farrales (लेखक), Nitesh K. Kunda (लेखक), Aaron Muth (लेखक), Vivek Gupta (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2020-02-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Non-small cell lung cancer (NSCLC) is a global disorder, treatment options for which remain limited with resistance development by cancer cells and off-target events being major roadblocks for current therapies. The discovery of new drug molecules remains time-consuming, expensive, and prone to fail...